Forget Dogecoin - Get This Silicon Valley Stock Instead

Below is an important message from one of our valued sponsors along with today's top headlines Forget Dogecoin -- Buy This Silicon Valley Startup Instead - Ad Disruptive Silicon Valley startup owns most innovative technology since Amazon. This could be like buying AMZN in the 1990s. Get the stock name here Top Stock to Own Amid the Coronavirus Pandemic What are the markets reacting to during the pandemic? This is the latest stock on the rise. Learn More Here The No. 1 Small Cap Stock to Own Today - Ad Ex-Wall Street CEO Dylan Jovine just released his #1 Small-Cap for 2021. It's a small Alabama firm that invented a new 5G "Arrow" that could replace all nuclear missiles. It's tiny compared to big defense contractors. But it beat them out to win the contract to make these weapons for the U.S. Learn More Here Return On Capital Employed Overview: Kubient During Q1, Kubient (NASDAQ:KBNT) brought in sales totaling $707.76 thousand. However, earnings decreased 16.2%, resulting in a loss of $1.82 million. In Q4, Kubient brought in $1.15 million in sales but lost $2.18 million in earnings. Learn More Here Redhill Biopharma: Q1 Earnings Insights   Shares of Redhill Biopharma (NASDAQ:RDHL) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share were flat 0.00% year over year to ($0.05), which beat the estimate of ($0.34). Learn More Here Forget Stock Options, Try This Trading Strategy - Ad This investment was reserved exclusively for the ultra-rich for decades...Today it's available to the public for as little as 15¢... Learn More Here CAN-FITE BIOPHARMA ANNOUNCES ADVANCEMENT OF CLINICAL STUDIES AND NEW EUROPEAN LICENSING AGREEMENTS by Mark Gilman Can-Fite BioPharma Ltd. (NYSE: CANF) (TASE: CFBI), an Israeli-based biotechnology company advancing a pipeline of proprietary small-molecule drugs that address inflammatory, cancer and liver diseases, continues to expand its reach in the treatment of cancer, liver and inflammatory disease. Learn More Here QAD: Q1 Earnings Insights Shares of QAD (NASDAQ:QADA) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 550.00% year over year to $0.09, which missed the estimate of $0.12. Learn More Here Cannabis Countdown: Top 10 Marijuana and Psychedelics Industry News Stories of the Week Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap. Learn More Here Retirement Can Still Be Profitable - Find Out How - Ad Expert options trader Dave Aquino's e-book "How to Master Retirement Trade" is sending new traders into early retirement. Learn the tricks to spotting the best time to trade each morning when you download the new e-book. Learn More Here Bitcoin Mining Caused Deaths In Chinese Coal Mines, Report Shows Last week, Chinese regulators decided to crack down on the mining of Bitcoin (CRYPTO: BTC) and other cryptocurrencies partly due to environmental concerns and a surge in the illegal coal extraction. Learn More Here Recap: DXC Technology Q4 Earnings Shares of DXC Technology (NYSE:DXC) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 38.33% year over year to $0.74, which beat the estimate of $0.70. Learn More Here Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. This is not individualized investment management. This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault. Copyright © 2021.SystemTrading.ca 20 De Boers Dr., Toronto, ON M3J 0G7 Unit # 339 | Unsubscribe Subscribe to: Post Comments (Atom) Total Pageviews Featured Big Welcome to the Rapid Cash Accumulator INSTANTLY DOWNLOAD YOUR FREE COPY OF MY RAPID CASH ACCUMULATOR SYSTEM RIGHT HERE. Download it instantly here! In the next two minutes,... Category Analysis Bitcoin Breaking News English No Deposit Bonus System forex Popular Posts | Stock Market News, Stock Advice & Trading Tips | Stock Market News... Intraday technical levels and trading recommendations for December 8, 2017 Intraday technical levels and trading recommendations for EUR/USD for December 8, 2017 2017-12-08 Monthly Outlook In January 2015, the EUR/U... New megatrend mints millionaire investors? Dear Investor, You may not have realiz... Forex analysis review Forex analysis review Forecast for AUD/USD on June 3, 2020 Forecast for USD/JPY on June 3, 2020 Co... The Short Squeeze of the Century Is Back. These 2 Stocks Could Explode   May 30, 2021   Take Advantage of This... FXStreet Team posted new content ... $10K in Value But not for you  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ... Home Home Bitcoin System forex Analysis No Deposit Bonus Powered by Blogger.